Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y

Article type: Research Article

Authors: Gasic-Milenkovic, Jovana | Loske, Claudia | Münch, Gerald^{; *}

Affiliations: Neuroimmunological Cell Biology Unit, Interdisciplinary Center for Clinical Research (IZKF) Leipzig, Johannisallee 30a, 04103 Leipzig, Germany

Correspondence: [*] Corresponding author: Dr. Gerald Münch PD, Nachwuchsgruppe Neuroimmunologische Zellbiologie, IZKF Leipzig, Johannissallee 30a, 04103 Leipzig, Germany. Tel.: +49 341 9715 945; Fax: +49 341 9715 979; E-mail: mueg@medizin.uni-leipzig.de.

Abstract: Advanced glycation endproducts (AGEs), sugar-derived protein modifications and lipid peroxidation products are prominent features of Alzheimer's disease. AGEs accumulate on β-amyloid plaques during the course of the disease and can exert chronic oxidative stress via receptor-mediated mechanisms. Lipid peroxidation products such as hydroxynonenal, further markers of oxidative stress, are also increased in Alzheimer's diesease. In this study we present evidence for a direct biochemical link between AGEs and lipid peroxidation. Our results show that AGEs induce lipid peroxidation in a neuronal cell line in a dose-dependant manner, and that blocking the specific AGE-receptor RAGE, as well as using different antioxidants (α-lipoic acid, N-acetylcysteine, 17 β-estradiol or aminoguanidine) can reduce the AGE-mediated formation of lipid peroxidation products. Thus, both RAGE antagonists and scavengers of oxygen free radicals could be useful in protecting brain tissue from lipid peroxidation and its pathophysilogical consequences that occur in Alzheimer's disease.

Keywords: glycation, Alzheimer's disease, lipid peroxidation, antioxidants, RAGE, α-lipoic acid, hydroxynonenal

DOI: 10.3233/JAD-2003-5104

Journal: Journal of Alzheimer's Disease, vol. 5, no. 1, pp. 25-30, 2003